Asset Management One Co. Ltd. Sells 14,989 Shares of Cigna Corporation (CI)
Asset Management One Co. Ltd. lowered its stake in shares of Cigna Corporation (NYSE:CI) by 3.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 404,655 shares of the health services provider’s stock after selling 14,989 shares during the period. Asset Management One Co. Ltd. owned 0.16% of Cigna worth $75,647,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of the business. Wetherby Asset Management Inc. raised its position in shares of Cigna by 0.8% in the second quarter. Wetherby Asset Management Inc. now owns 4,192 shares of the health services provider’s stock worth $702,000 after buying an additional 33 shares in the last quarter. Cadence Capital Management LLC raised its position in shares of Cigna by 0.3% in the second quarter. Cadence Capital Management LLC now owns 9,598 shares of the health services provider’s stock worth $1,607,000 after buying an additional 33 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its position in shares of Cigna by 2.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,760 shares of the health services provider’s stock worth $295,000 after buying an additional 40 shares in the last quarter. Veritable L.P. raised its position in shares of Cigna by 0.5% in the second quarter. Veritable L.P. now owns 8,220 shares of the health services provider’s stock worth $1,376,000 after buying an additional 41 shares in the last quarter. Finally, MML Investors Services LLC raised its position in shares of Cigna by 0.8% in the second quarter. MML Investors Services LLC now owns 5,774 shares of the health services provider’s stock worth $967,000 after buying an additional 43 shares in the last quarter. Hedge funds and other institutional investors own 87.85% of the company’s stock.
In other news, Director William D. Zollars sold 1,232 shares of the firm’s stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $187.23, for a total transaction of $230,667.36. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CAO Mary T. Hoeltzel sold 575 shares of the firm’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $197.03, for a total value of $113,292.25. Following the transaction, the chief accounting officer now directly owns 2,499 shares in the company, valued at $492,377.97. The disclosure for this sale can be found here. Insiders have sold 36,203 shares of company stock worth $7,211,251 over the last ninety days. Insiders own 1.30% of the company’s stock.
A number of brokerages recently issued reports on CI. Royal Bank Of Canada reiterated a “buy” rating and issued a $185.00 price objective on shares of Cigna in a research report on Wednesday, August 9th. BidaskClub upgraded Cigna from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 18th. Morgan Stanley increased their price objective on Cigna from $188.00 to $195.00 and gave the stock an “overweight” rating in a research report on Thursday, August 17th. BMO Capital Markets assumed coverage on Cigna in a research report on Monday, October 16th. They set a “market perform” rating and a $210.00 price target on the stock. Finally, Citigroup raised their price target on Cigna from $198.00 to $231.00 and gave the company a “buy” rating in a research report on Friday, November 3rd. Three research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. Cigna presently has a consensus rating of “Buy” and a consensus target price of $201.50.
Shares of Cigna Corporation (CI) opened at $204.21 on Thursday. Cigna Corporation has a 12-month low of $131.03 and a 12-month high of $212.46. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.39 and a current ratio of 0.39. The firm has a market capitalization of $50,325.72, a PE ratio of 19.67, a price-to-earnings-growth ratio of 1.56 and a beta of 0.50.
Cigna (NYSE:CI) last released its quarterly earnings results on Thursday, November 2nd. The health services provider reported $2.83 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.36 by $0.47. Cigna had a return on equity of 18.85% and a net margin of 5.74%. The business had revenue of $10.38 billion for the quarter, compared to the consensus estimate of $10.17 billion. During the same quarter last year, the business posted $1.94 earnings per share. The company’s revenue for the quarter was up 5.1% on a year-over-year basis. equities research analysts forecast that Cigna Corporation will post 10.34 EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This news story was originally published by Watch List News and is the property of of Watch List News. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://www.watchlistnews.com/asset-management-one-co-ltd-sells-14989-shares-of-cigna-corporation-ci/1749319.html.
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.